搜索
60 Degrees Pharmaceuticals Inc
SXTP添加自选
1.710USD
-0.040-2.29%
收盘 07/02, 13:00（美东）报价延迟15分钟
1.75M总市值
亏损市盈率 TTM
关于 60 Degrees Pharmaceuticals Inc 公司
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
60 Degrees Pharmaceuticals Inc简介
公司代码SXTP
公司名称60 Degrees Pharmaceuticals Inc
上市日期Jul 12, 2023
CEODow (Geoffrey S)
员工数量3
证券类型Ordinary Share
年结日Jul 12
公司地址1025 Connecticut Avenue Nw
城市WASHINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编20036
电话12023275422
网址https://60degreespharma.com/
公司代码SXTP
上市日期Jul 12, 2023
CEODow (Geoffrey S)
60 Degrees Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
59.00
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
常见问题
60 Degrees Pharmaceuticals Inc的前五大股东是谁？
60 Degrees Pharmaceuticals Inc 的前五大股东如下：Dr. Geoffrey S. Dow, Ph.D.
有多少机构持有60 Degrees Pharmaceuticals Inc(SXTP)的股份？
截至2026Q1，共有27家机构持有60 Degrees Pharmaceuticals Inc的股份，合计持有的股份价值约为228.38K，占公司总股份的8.66%。与2025Q4相比，机构持股有所增加，增幅为141573.00。